A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® vaccine in Healthy Volunteers

Registry ID

EUCTR2012-001101-24

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

CSL Limited

Start date

2012-04-19

Completion date

2012-06-01

Last update

2026-08-16

Conditions

• Influenza, human

Summary

To evaluate the immunogenicity of the 2012/2013 formulation of the Enzira® vaccine in ‘Adults’ (aged 18 to 59 years) and in ‘Older Adults’ (aged 60 years or older) according to the criteria outlined in the CPMP Criteria.

Locations

• , , UK

View on source registry